Abstract:Abstract Background Bicuspid aortic valve (BAV) is the most common congenital cardiovascular disease in general population and is frequently associated with the development of thoracic aortic aneurysm (TAA). There is no effective strategy to intervene with TAA progression due to an incomplete understanding of the pathogenesis. Insufficiency of NOTCH1 expression is highly related to BAV-TAA, but the underlying mechanism remains to be clarified. Methods A comparative proteomics analysis was used to explore the biological differences between non-diseased and BAV-TAA aortic tissues. A microfluidics-based aorta-on-a-chip model was constructed to evaluate the effect of NOTCH1 deficiency on contractile phenotype and mitochondrial dynamics of human aortic smooth muscle cells (HAoSMCs). Results Protein analyses of human aortic tissues showed the insufficient expression of NOTCH1 and impaired mitochondrial dynamics in BAV-TAA. HAoSMCs with NOTCH1-knockdown exhibited reduced contractile phenotype and were accompanied by attenuated mitochondrial fusion. Furthermore, we identified that mitochondrial fusion activators (leflunomide and teriflunomide) or mitochondrial fission inhibitor (Mdivi-1) partially rescued the disorders of mitochondrial dynamics in HAoSMCs derived from BAV-TAA patients. Conclusions The aorta-on-a-chip model simulates the human pathophysiological parameters of aorta biomechanics and provides a platform for molecular mechanism studies of aortic disease and related drug screening. This aorta-on-a-chip model and human tissue proteomic analysis revealed that impaired mitochondrial dynamics could be a potential therapeutic target for BAV-TAA. Funding National Key R&D Program of China, National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, Shanghai Science and Technology Commission, and Shanghai Municipal Education Commission.

NOTCH Signaling in Aortic Valve Development and Calcific Aortic Valve Disease

Identification of Key Genes in Calcific Aortic Valve Disease by Integrated Bioinformatics Analysis.

Notch-Tnf Signalling is Required for Development and Homeostasis of Arterial Valves

Developmental Mechanisms Of Aortic Valve Malformation And Disease

Abnormal mechanical stress on bicuspid aortic valve induces valvular calcification and inhibits Notch1/NICD/Runx2 signal

Endothelial Nitric Oxide Signaling Regulates Notch1 in Aortic Valve Disease.

Notch signaling in cardiovascular disease and calcification

Co-ordinating Notch, BMP, and TGF-β Signaling During Heart Valve Development.

A Notch‐dependent Transcriptional Hierarchy Promotes Mesenchymal Transdifferentiation in the Cardiac Cushion

Targeted Next-Generation Sequencing Identified ADAMTS5 As Novel Genetic Substrate in Patients with Bicuspid Aortic Valve.

Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase

Notch signaling pathway and its role in cardiac development,congenital heart disease and myocardial regeneration

An Essential Role for Notch in Neural Crest During Cardiovascular Development and Smooth Muscle Differentiation.

Human Genetics of Semilunar Valve and Aortic Arch Anomalies

Notch and interacting signalling pathways in cardiac development, disease, and regeneration

Endocardial to Myocardial Notch-Wnt-bmp Axis Regulates Early Heart Valve Development.

Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency

Control of sinus venous valve and sinoatrial node development by endocardial NOTCH1.

[Role of the Canonical Wnt Signaling Pathway in Heart Valve Development].

Aorta-on-a-chip reveals impaired mitochondrial dynamics as a therapeutic target for aortic aneurysm in bicuspid aortic valve disease

NOTCH maintains developmental cardiac gene network through WNT5A